1 | IL1RL1, IL33
|
| Perinatal Licensing of Thermogenesis by IL-33 and ST2.
|
| Odegaard JI, Lee MW, Sogawa Y, Bertholet AM, Locksley RM, Weinberg DE, Kirichok Y, Deo RC, Chawla A.
|
| Cell 166(4):841-54. doi: 10.1016/j.cell.2016.06.040.
2016
|
2 | IL1RL1
|
| The IL33/ST2 axis in Sjogren syndrome in relation to disease activity.
|
| Margiotta DP, Navarini L, Vadacca M, Lo Vullo M, Pignataro F, Basta F, Afeltra A.
|
| Eur Rev Med Pharmacol Sci 20(7):1295-9.
2016
|
3 | IL1RL1, IL33
|
| Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.
|
| Milosavljevic MZ, Jovanovic IP, Pejnovic NN, Mitrovic SL, Arsenijevic NN, Simovic Markovic BJ, Lukic ML.
|
| Oncotarget 7(14):18106-15. doi: 10.18632/oncotarget.7635.
2016
|
4 | IL1RL1
|
| ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.
|
| Rood JE, Rao S, Paessler M, Kreiger PA, Chu N, Stelekati E, Wherry EJ, Behrens EM.
|
| Blood 127(4):426-35. doi: 10.1182/blood-2015-07-659813.
2016
|
5 | IL1RL1, IL33
|
| Expression of interleukin-33 and its receptor ST2 in periapical granulomas and radicular cysts.
|
| Velickovic M, Pejnovic N, Petrovic R, Mitrovic S, Jeftic I, Kanjevac T, Lukic A.
|
| J Oral Pathol Med 45(1):70-6. doi: 10.1111/jop.12312.
2016
|
6 | IL1RL1, IL33
|
| Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.
|
| Cohen ES, Scott IC, Majithiya JB, Rapley L, Kemp BP, England E, Rees DG, Overed-Sayer CL, Woods J, Bond NJ, Veyssier CS, Embrey KJ, Sims DA, Snaith MR, Vousden KA, Strain MD, Chan DT, Carmen S, Huntington CE, Flavell L, Xu J, Popovic B, Brightling CE, Vaughan TJ, Butler R, Lowe DC, Higazi DR, Corkill DJ, May RD, Sleeman MA, Mustelin T.
|
| Nat Commun 6:8327. doi: 10.1038/ncomms9327.
2015
|
7 | IL1RL1, IL33
|
| The IL-33/ST2 axis is specifically required for development of adipose tissue-resident regulatory T cells.
|
| Hu ZQ, Zhao WH.
|
| Cell Mol Immunol 12(5):521-4. doi: 10.1038/cmi.2015.49. No abstract available.
2015
|
8 | IL1RL1
|
| ST2 deletion increases inflammatory bone destruction in experimentally induced periapical lesions in mice.
|
| Velickovic M, Pejnovic N, Mitrovic S, Radosavljevic G, Jovanovic I, Kanjevac T, Jovicic N, Lukic A.
|
| J Endod 41(3):369-75. doi: 10.1016/j.joen.2014.11.017.
2015
|
9 | IL1RL1, IL33
|
| Role of IL-33 and its receptor in T cell-mediated autoimmune diseases.
|
| Zhao Q, Chen G.
|
| Biomed Res Int 2014:587376. doi: 10.1155/2014/587376.
2014
|
10 | IL1RL1, IL33
|
| IL-33/ST2 axis promotes mast cell survival via BCLXL.
|
| Wang JX, Kaieda S, Ameri S, Fishgal N, Dwyer D, Dellinger A, Kepley CL, Gurish MF, Nigrovic PA.
|
| Proc Natl Acad Sci U S A 111(28):10281-6. doi: 10.1073/pnas.1404182111.
2014
|
11 | IL1RL1
|
| The variations in the IL1RL1 gene and susceptibility to preeclampsia.
|
| Chen P, Zhang K, Zhou B, Zhang Z, Song Y, Pu Y, Yang Y, Zhang Y, Zhou R, Wang T, Zhang L.
|
| Immunol Invest 43(5):424-35. doi: 10.3109/08820139.2013.879173.
2014
|
12 | IL1RL1, IL33
|
| Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.
|
| Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A.
|
| J Alzheimers Dis 40(2):297-308. doi: 10.3233/JAD-132081.
2014
|
13 | IL1RAP, IL1RL1, IL33
|
| Structural insights into the interaction of IL-33 with its receptors.
|
| Liu X, Hammel M, He Y, Tainer JA, Jeng US, Zhang L, Wang S, Wang X.
|
| Proc Natl Acad Sci U S A 110(37):14918-23. doi: 10.1073/pnas.1308651110. Epub 2013 Aug 26.
2013
|
14 | IL1RL1, IL33, IL6, IL8, TMED1
|
| The GOLD domain-containing protein TMED1 is involved in interleukin-33 signaling.
|
| Connolly DJ, O'Neill LA, McGettrick AF.
|
| J Biol Chem 288(8):5616-23. doi: 10.1074/jbc.M112.403899. Epub 2013 Jan 14.
2013
|
15 | IL1RL1, IL33
|
| A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
|
| Lin J, Zhang L, Zhao G, Su Z, Deng R, Pflugfelder SC, Li DQ.
|
| PLoS One 8(4):e60963. doi: 10.1371/journal.pone.0060963.
2013
|
16 | GATA1, GATA2, IL1RL1
|
| GATA2 is a critical transactivator for the human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression.
|
| Baba Y, Maeda K, Yashiro T, Inage E, Kasakura K, Suzuki R, Niyonsaba F, Hara M, Tanabe A, Ogawa H, Okumura K, Ohtsuka Y, Shimizu T, Nishiyama C.
|
| J Biol Chem 287(39):32689-96.
2012
|
17 | IL1RL1
|
| Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells.
|
| Nagata A, Takezako N, Tamemoto H, Ohto-Ozaki H, Ohta S, Tominaga S, Yanagisawa K.
|
| Cell Mol Immunol 9(5):399-409. doi: 10.1038/cmi.2012.29.
2012
|
18 | IL1RL1, IL33
|
| ST2 and IL-33 in pregnancy and pre-eclampsia.
|
| Granne I, Southcombe JH, Snider JV, Tannetta DS, Child T, Redman CW, Sargent IL.
|
| PLoS One 6(9):e24463. doi: 10.1371/journal.pone.0024463.
2011
|
19 | IL1RL1, IL33
|
| Disease-associated functions of IL-33: the new kid in the IL-1 family.
|
| Liew FY, Pitman NI, McInnes IB.
|
| Nat Rev Immunol 10(2):103-10. Epub 2010 Jan 18. Review.PMID: 20081870 2010
|
20 | IL1RL1
|
| Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
|
| Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM, McInnes IB, Dargie HJ, McMurray JJ.
|
| J Am Coll Cardiol 55(3):243-50.PMID: 20117403 2010
|
21 | IL1RL1
|
| Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
|
| Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL, Vázquez R, Puig T, Valdés M, Cinca J, de Luna AB, Bayes-Genis A; MUSIC Investigators.
|
| J Am Coll Cardiol 54(23):2174-9.PMID: 19942089 2009
|
22 | IL1RL1, IL33
|
| Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling.
|
| Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, Lee RT.
|
| Circ Heart Fail 2(6):684-91. Epub 2009 Sep 22.PMID: 19919994 2009
|
23 | IL1RL1
|
| ST2 and adrenomedullin in heart failure.
|
| Kakkar R, Lee RT.
|
| Heart Fail Clin 5(4):515-27.PMID: 19631176 2009
|
24 | IL1RL1
|
| Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
|
| Rehman SU, Mueller T, Januzzi JL Jr.
|
| J Am Coll Cardiol 52(18):1458-65.PMID: 19017513 2008
|
25 | IL1RL1, IL33
|
| The IL-33/ST2 pathway: therapeutic target and novel biomarker.
|
| Kakkar R, Lee RT.
|
| Nat Rev Drug Discov 7(10):827-40. Review.PMID: 18827826 2008
|
26 | IL1RL1
|
| Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis.
|
| Shimizu M, Matsuda A, Yanagisawa K, Hirota T, Akahoshi M, Inomata N, Ebe K, Tanaka K, Sugiura H, Nakashima K, Tamari M, Takahashi N, Obara K, Enomoto T, Okayama Y, Gao PS, Huang SK, Tominaga S, Ikezawa Z, Shirakawa T.
|
| Hum Mol Genet 14(19):2919-27. Epub 2005 Aug 23. 2005
|
27 | IL1RL1
|
| Identification of human ST2 protein in the sera of patients with autoimmune diseases.
|
| Kuroiwa K, Arai T, Okazaki H, Minota S, Tominaga S.
|
| Biochem Biophys Res Commun 284(5):1104-8. 2001
|
28 | IL1RL1
|
| Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V.
|
| Tago K, Noda T, Hayakawa M, Iwahana H, Yanagisawa K, Yashiro T, Tominaga S.
|
| Biochem Biophys Res Commun 285(5):1377-83. 2001
|
29 | IL1RL1, TMED1
|
| The cloning and nucleotide sequence of human ST2L cDNA.
|
| Li H, Tago K, Io K, Kuroiwa K, Arai T, Iwahana H, Tominaga S, Yanagisawa K.
|
| Genomics 67(3):284-90. 2000
|
30 | IL1RL1, IL1RL2, IL18R1
|
| Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q.
|
| Dale M, et al.
|
| Genomics 57(1):177-9. 1999
|
31 | IL1RL1
|
| Assignment of the human ST2 gene to chromosome 2 at q11.2.
|
| Tominaga S, et al.
|
| Hum Genet 97 : 561-563. 1996
|
32 | IL1RL1
|
| Nucleotide sequence of a complementary DNA for human ST2.
|
| Tominaga S, et al.
|
| Biochim Biophys Acta 1171 : 215-218. 1992
|